Steven Cohen Axonics, Inc. Transaction History

Point72 Asset Management, L.P.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$48.64 - $62.51 $29.2 Million - $37.6 Million	600,821 Added 1038.15%	658,695 $37 Million
Q2 2023 Aug 14, 2023	SELL	$47.99 - $60.21 $48.6 Million - $61 Million	-1,012,626 Reduced 94.59%	57,874 $2.92 Million
Q1 2023 May 15, 2023	BUY	$52.6 - $67.34 $56.3 Million - $72.1 Million	1,070,500 New	1,070,500 $58.4 Million
Q2 2022 Aug 15, 2022	BUY	$39.5 - $64.42 $11 Million - $17.9 Million	278,060 Added 126.74%	497,446 $28.2 Million
Q1 2022 May 16, 2022	BUY	$43.74 - $62.76 $9.6 Million - $13.8 Million	219,386 New	219,386 $13.7 Million
Q2 2021 Aug 16, 2021	SELL	$51.39 - $66.9 $8.52 Million - $11.1 Million	-165,787 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$49.14 - $59.89 $8.15 Million - $9.93 Million	165,787 New	165,787 $9.93 Million
Q4 2020 Feb 16, 2021	SELL	$42.19 - $51.5 $22.4 Million - $27.3 Million	-530,819 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$35.33 - $51.04 $1.1 Million - $1.59 Million	31,248 Added 6.25%	530,819 $27.1 Million
Q2 2020 Aug 14, 2020	SELL	$22.91 - $39.83 $8.34 Million - $14.5 Million	-364,150 Reduced 42.16%	499,571 $17.5 Million
Q1 2020 May 15, 2020	BUY	$16.44 - $37.73 $9.44 Million - $21.7 Million	574,502 Added 198.64%	863,721 $21.9 Million
Q4 2019 Feb 14, 2020	BUY	$19.57 - $28.96 $5.66 Million - $8.38 Million	289,219 New	289,219 $8.01 Million
Q1 2019 May 15, 2019	SELL	$13.32 - $24.35 $3.76 Million - $6.88 Million	-282,608 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$13.2 - $16.43 $3.73 Million - $4.64 Million	282,608 New	282,608 $4.27 Million

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.